{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:49:08Z","timestamp":1772826548877,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03671-4","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:06:41Z","timestamp":1745568401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of physician awareness and microbiological examination on incidence of COVID-19-associated pulmonary aspergillosis: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Li-jing","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-tong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-cheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-shan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"1","key":"3671_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/07853890.2022.2031274","volume":"54","author":"Q Fernandes","year":"2022","unstructured":"Fernandes Q, et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med. 2022;54(1):524\u201340.","journal-title":"Ann Med"},{"issue":"4","key":"3671_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s15010-021-01602-z","volume":"49","author":"WH Chong","year":"2021","unstructured":"Chong WH, et al. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection. 2021;49(4):591\u2013605.","journal-title":"Infection"},{"issue":"6","key":"3671_CR3","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","volume":"8","author":"A Alanio","year":"2020","unstructured":"Alanio A, et al. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020;8(6):e48\u20139.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"3671_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/jof6020091","volume":"6","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar A, et al. COVID-19 associated pulmonary aspergillosis (CAPA)-From immunology to treatment. J Fungi (Basel). 2020;6(2):91.","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"3671_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3904\/kjim.2022.069","volume":"37","author":"R Lee","year":"2022","unstructured":"Lee R, et al. Risk factors and clinical impact of COVID-19-associated pulmonary aspergillosis: multicenter retrospective cohort study. Korean J Intern Med. 2022;37(4):851\u201363.","journal-title":"Korean J Intern Med"},{"issue":"1","key":"3671_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s15010-022-01907-7","volume":"51","author":"M Erami","year":"2023","unstructured":"Erami M, et al. COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia. Infection. 2023;51(1):223\u201330.","journal-title":"Infection"},{"issue":"5","key":"3671_CR7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/diagnostics12051201","volume":"12","author":"T Fischer","year":"2022","unstructured":"Fischer T, et al. Clinical and imaging features of COVID-19-Associated pulmonary aspergillosis. Diagnostics (Basel). 2022;12(5):1201.","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"3671_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/jof8020096","volume":"8","author":"RG Bentvelsen","year":"2022","unstructured":"Bentvelsen RG, et al. Regional impact of COVID-19-Associated pulmonary aspergillosis (CAPA) during the first wave. J Fungi (Basel). 2022;8(2):96.","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"3671_CR9","first-page":"10","volume":"47","author":"Critical care medicine group of chinese association of chest physicians; chinese thoracic society","year":"2024","unstructured":"Critical care medicine group of chinese association of chest physicians; chinese thoracic society. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary aspergillosis and mucormycosis]. Zhonghua Jie He He Hu Xi Za Zhi. 2024;47(1):10\u201323. Chinese.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"6","key":"3671_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1473-3099(21)00066-9","volume":"21","author":"K Jabeen","year":"2021","unstructured":"Jabeen K, et al. Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis. Lancet Infect Dis. 2021;21(6):767.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"3671_CR11","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.3201\/eid2711.211174","volume":"27","author":"NAF Janssen","year":"2021","unstructured":"Janssen NAF, et al. Multinational observational cohort study of COVID-19-Associated pulmonary aspergillosis1. Emerg Infect Dis. 2021;27(11):2892\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"3671_CR12","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S1473-3099(21)00060-8","volume":"21","author":"N Permpalung","year":"2021","unstructured":"Permpalung N, et al. Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis. Lancet Infect Dis. 2021;21(6):766\u20137.","journal-title":"Lancet Infect Dis"},{"key":"3671_CR13","doi-asserted-by":"crossref","unstructured":"Delli\u00e8re S et al. Combination of mycological criteria: a better surrogate to identify covid-19-associated pulmonary aspergillosis patients and evaluate prognosis? J Clin Microbiol. 2022;60(3):e0216921. doi: 10.1128\/JCM.02169-21. Epub 2022 Jan 5. PMID: 34985983; PMCID: PMC8925884.","DOI":"10.1128\/jcm.02169-21"},{"issue":"4","key":"3671_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","volume":"28","author":"J Prattes","year":"2022","unstructured":"Prattes J, et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European confederation of medical mycology. Clin Microbiol Infect. 2022;28(4):580\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"3671_CR15","doi-asserted-by":"publisher","first-page":"1287496","DOI":"10.3389\/fcimb.2023.1287496","volume":"13","author":"X Zhou","year":"2023","unstructured":"Zhou X, et al. Risk factors and the value of Microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate Microbiological examinations are crucial for the timely diagnosis of CAPA. Front Cell Infect Microbiol. 2023;13:1287496.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"3671_CR16","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21(6):e149\u201362.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"3671_CR17","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00134-021-06471-6","volume":"47","author":"J Prattes","year":"2021","unstructured":"Prattes J, et al. Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med. 2021;47(10):1158\u201360.","journal-title":"Intensive Care Med"},{"issue":"2","key":"3671_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/jof9020131","volume":"9","author":"MP Ledoux","year":"2023","unstructured":"Ledoux MP, et al. Invasive pulmonary aspergillosis. J Fungi (Basel). 2023;9(2):131.","journal-title":"J Fungi (Basel)"},{"issue":"8","key":"3671_CR19","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00134-021-06449-4","volume":"47","author":"PE Verweij","year":"2021","unstructured":"Verweij PE, et al. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021;47(8):819\u201334.","journal-title":"Intensive Care Med"},{"issue":"11","key":"3671_CR20","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00134-021-06510-2","volume":"47","author":"J Prattes","year":"2021","unstructured":"Prattes J, et al. COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges. Intensive Care Med. 2021;47(11):1339\u201340.","journal-title":"Intensive Care Med"},{"issue":"8","key":"3671_CR21","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","volume":"7","author":"M Hoenigl","year":"2022","unstructured":"Hoenigl M, et al. COVID-19-associated fungal infections. Nat Microbiol. 2022;7(8):1127\u201340.","journal-title":"Nat Microbiol"},{"issue":"7","key":"3671_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/14737159.2018.1488589","volume":"18","author":"MW McCarthy","year":"2018","unstructured":"McCarthy MW, et al. Galactomannan antigenemia as a biomarker for therapeutic response of invasive aspergillosis: implications for clinical trial design and patient care. Expert Rev Mol Diagn. 2018;18(7):601\u20134.","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"3671_CR23","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;63(4):e1\u201360.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3671_CR24","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s11046-020-00493-2","volume":"185","author":"E Nasri","year":"2020","unstructured":"Nasri E, et al. Fatal invasive pulmonary aspergillosis in COVID-19 patient with acute myeloid leukemia in Iran. Mycopathologia. 2020;185(6):1077\u201384.","journal-title":"Mycopathologia"},{"issue":"6","key":"3671_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1164\/rccm.202310-1815VP","volume":"209","author":"S Feys","year":"2024","unstructured":"Feys S, et al. Fungal fog in viral storms: necessity for rigor in aspergillosis diagnosis and research. Am J Respir Crit Care Med. 2024;209(6):631\u20133.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3671_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/jof9030312","volume":"9","author":"J Peral","year":"2023","unstructured":"Peral J, et al. Managing the next wave of influenza and\/or SARS-CoV-2 in the ICU-Practical recommendations from an expert group for CAPA\/IAPA patients. J Fungi (Basel). 2023;9(3):312.","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"3671_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/jof8010049","volume":"8","author":"CJ Wu","year":"2022","unstructured":"Wu CJ, et al. Clinical and Microbiological characteristics of Culture-Positive, Influenza-Associated pulmonary aspergillosis: A Single-Center study in Southern Taiwan, 2016\u20132019. J Fungi (Basel). 2022;8(1):49.","journal-title":"J Fungi (Basel)"},{"issue":"6","key":"3671_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","volume":"20","author":"CY Chiu","year":"2019","unstructured":"Chiu CY, et al. Clinical metagenomics. Nat Rev Genet. 2019;20(6):341\u201355.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"3671_CR29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5045\/br.2017.52.4.300","volume":"52","author":"R Kim","year":"2017","unstructured":"Kim R, et al. The limited role of serum Galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on Micafungin prophylaxis: a retrospective study. Blood Res. 2017;52(4):300\u20136.","journal-title":"Blood Res"},{"issue":"12","key":"3671_CR30","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/jof7121059","volume":"7","author":"O Shadrivova","year":"2021","unstructured":"Shadrivova O, et al. COVID-19-Associated pulmonary aspergillosis in Russia. J Fungi (Basel). 2021;7(12):1059.","journal-title":"J Fungi (Basel)"},{"key":"3671_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jhin.2021.04.012","volume":"113","author":"WH Chong","year":"2021","unstructured":"Chong WH, et al. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect. 2021;113:115\u201329.","journal-title":"J Hosp Infect"},{"issue":"3","key":"3671_CR32","doi-asserted-by":"publisher","first-page":"e0185922","DOI":"10.1128\/jcm.01859-22","volume":"61","author":"M Hoenigl","year":"2023","unstructured":"Hoenigl M, et al. Metagenomic Next-Generation sequencing of plasma for diagnosis of COVID-19-Associated pulmonary aspergillosis. J Clin Microbiol. 2023;61(3):e0185922.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"3671_CR33","doi-asserted-by":"publisher","first-page":"e0052622","DOI":"10.1128\/jcm.00526-22","volume":"60","author":"DC Gaston","year":"2022","unstructured":"Gaston DC, et al. Evaluation of metagenomic and targeted Next-Generation sequencing workflows for detection of respiratory pathogens from Bronchoalveolar lavage fluid specimens. J Clin Microbiol. 2022;60(7):e0052622.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"3671_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/myc.13433","volume":"65","author":"JN de Almeida Jr","year":"2022","unstructured":"de Almeida JN Jr, et al. COVID-19-associated aspergillosis in a Brazilian referral centre: diagnosis, risk factors and outcomes. Mycoses. 2022;65(4):449\u201357.","journal-title":"Mycoses"},{"key":"3671_CR35","doi-asserted-by":"publisher","first-page":"753659","DOI":"10.3389\/fmed.2021.753659","volume":"8","author":"J Xu","year":"2021","unstructured":"Xu J, et al. Risk factors for invasive aspergillosis in patients admitted to the intensive care unit with coronavirus disease 2019: A multicenter retrospective study. Front Med (Lausanne). 2021;8:753659.","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"3671_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/toxins12070439","volume":"12","author":"G Cohen","year":"2020","unstructured":"Cohen G. Immune dysfunction in uremia 2020. Toxins (Basel). 2020;12(7):439.","journal-title":"Toxins (Basel)"},{"issue":"3","key":"3671_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/imm.13706","volume":"171","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, et al. The alterations of innate immunity and enhanced severity of infections in diabetes mellitus. Immunology. 2024;171(3):313\u201323.","journal-title":"Immunology"},{"key":"3671_CR38","first-page":"42","volume":"4","author":"N W\u00e9ry","year":"2014","unstructured":"W\u00e9ry N. Bioaerosols from composting facilities\u2013a review. Front Cell Infect Microbiol. 2014;4:42.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"3671_CR39","doi-asserted-by":"publisher","first-page":"e00140","DOI":"10.1128\/CMR.00140-18","volume":"33","author":"JP Latg\u00e9","year":"2019","unstructured":"Latg\u00e9 JP, et al. Aspergillus fumigatus and Aspergillosis in 2019. Clin Microbiol Rev. 2019;33(1):e00140\u201318.","journal-title":"Clin Microbiol Rev"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03671-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03671-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03671-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:06:44Z","timestamp":1745568404000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03671-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3671"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03671-4","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki (revised in 2013), approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University (KY2024-R216) and the informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}